Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzastaurin in Relapsed Mantle Cell Lymphoma
NCT00088205Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2004
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of enzastaurin in mantle cell lymphoma (MCL), sponsored by Eli Lilly and Company. Started Mar 2004; status: completed.
02
Drugs
enzastaurin
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00088205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00088205.